My name is Pinky Damani, I'm with Bayer for 14yrs, originally from Mumbai, India, but settled in NJ, USA. I love to play cricket and badminton. Married, 2 children. Currently, working on Spectrum DMW platform with CDSA, Accenture and Oracle, part of Data Transformation and Ingestion Team, I'm very excited and happy to be part of DSA&I. Looking forward to our connect!

At Language of Life, LoL, we combine state-of-the-art machine learning models, bioinformatics and expert knowledge to understand and design large biomolecules (RNA, DNA, Proteins), helping deliver the best drug, faster and cheaper, to address our patients’ needs. Our objectives are, 1) Drug the undruggable 2) Target any modality 3) Efficient Dry lab – Wet lab loops 4) Understand Patient & Disease

Machine learning is a powerful tool that is increasingly being applied to a wide range of sectors and applications, from healthcare and medicine, to finance and marketing, to manufacturing and logistics. It is expected to drive productivity gains, enable innovation, and improve quality and efficiencies in many industries. We as a pharmaceutical company are constantly looking for new ways to improve our research and development pipeline so we can deliver innovative products and therapies that will provide patients with better treatment options. Machine learning offers many opportunities to improve processes and accelerate the discovery of new therapies, and we will continue to invest in this powerful tool to drive future advances in drug development. Our group, Machine Learning Research (MLR), has a proven track record in the field covering the areas of cell painting, large language modelling of proteins, and small molecule research. In this poster we give a broad overview over our projects and collaborations both internally and externally as well as showcasing our direct impact on the R&D pipeline. Artwork created using Stable Diffusion.